Back to Articles
22072026 Q3PrimeJGAAP

MEITO (2207) FY2026 Q3 Earnings Report

For FY2026 Q3, revenue came to ¥22.1B (+3.9% year on year) and operating income ¥1.3B (+1.5%). The segment drivers and cash flow follow.

MEITO CO.,LTD.

Foods/Foods


Quick View

MetricCurrent PeriodSame Period of Previous YearYoY
Revenue¥221.3B¥213.0B+3.9%
Operating Income¥12.7B¥12.5B+1.5%
Ordinary Income¥27.7B¥25.1B+10.4%
Net Income¥29.2B¥44.3B−34.0%
ROE4.8%8.1%-

Executive Summary

Although the Company secured revenue growth, net income declined significantly due to the absence of gains on the sale of investment securities recorded in the previous year, among other factors, making this an earnings period in which attention must be paid to earnings quality. Revenue was ¥221.3B (+3.9% YoY), Operating Income was ¥12.7B (+1.5%), and Ordinary Income was ¥27.7B (+10.4%), while Net Income decreased 34.0% from ¥44.3B in the previous year to ¥29.2B. The increase in Ordinary Income was primarily attributable to the expansion of non-operating income, including ¥13.7B in dividend income, while the decline in Net Income was affected by the difference in the scale of gains on the sale of investment securities recorded in the previous year (¥33.6B in the previous year → ¥14.5B in the current period).

Factors Affecting Earnings

【Revenue】Revenue was ¥221.3B (+3.9% YoY), led by the Food Business at ¥193.6B (+4.0%). The Chemical Products Business grew only modestly to ¥24.9B (+0.8%), while the Real Estate Business increased substantially to ¥2.7B (+29.8%), although its composition ratio was small at 1.2%. The Food Business accounted for 87.5% of total Company revenue and was the substantive primary driver of revenue growth.

【Profit and Loss】Operating Income was ¥12.7B (+1.5%), and the Operating Income margin decreased slightly to 5.7% from 5.9% in the previous year. Segment income from the Food Business improved substantially to ¥17.2B (+29.7%), while the Chemical Products Business posted a decline to ¥5.1B (-17.2%), restraining overall growth. Total segment income increased to ¥23.6B (+16.9%), but corporate-wide common expenses not attributable to individual segments (adjustments) increased to ¥10.8B from ¥7.6B in the previous year, an expansion of ¥3.2B that substantially offset the increase in Operating Income. Ordinary Income increased to ¥27.7B (+10.4%), supported by ¥16.5B in non-operating income, primarily consisting of ¥13.7B in dividend income, while Net Income was ¥29.2B (-34.0%) due to the decline in gains on the sale of investment securities to ¥14.5B from ¥33.6B in the previous year. Overall, the Company achieved revenue and profit growth at the Operating Income and Ordinary Income levels, but Net Income declined due to extraordinary income and expense factors.

Segment Analysis

The Food Business led overall profit growth, with revenue of ¥193.6B (+4.0%), segment income of ¥17.2B (+29.7%), and a margin of 8.9%, improving from 7.1% in the previous year. The Chemical Products Business recorded revenue of ¥24.9B (+0.8%), segment income of ¥5.1B (-17.2%), and a margin of 20.5%, down from 25.0% in the previous year, indicating deteriorating profitability despite being a highly profitable business. The Real Estate Business recorded revenue of ¥2.7B (+29.8%), segment income of ¥1.2B (+77.0%), and a high margin of 46.3%, but its absolute contribution to Company-wide profit was small. In addition, segment income was increased by ¥0.6B for the Food Business and ¥0.1B for the Chemical Products Business due to the change in the depreciation method for property, plant and equipment from the declining-balance method to the straight-line method. Accordingly, it should be noted that part of the Food Business’s profit growth represents an apparent improvement resulting from a change in accounting policy.

Key Financial Metrics

【Profitability】The Operating Income margin of 5.7% declined slightly from 5.9% in the previous year, with a structure consisting of a gross margin of 30.5% and an SG&A expense ratio of 24.7%. The Net Income margin of 13.2% was boosted by extraordinary income and expenses, including ¥14.5B in gains on the sale of investment securities, and must be assessed separately from recurring earnings power.【Cash Flow Quality】Comprehensive Income of ¥81.6B exceeded Net Income of ¥29.2B by ¥52.4B, primarily due to ¥53.9B in valuation differences on securities. The current period’s earnings level was significantly affected by valuation gains arising from market fluctuations.【Investment Efficiency】ROE was 4.8%, and the Equity Ratio was 61.1%, down from 65.9% in the previous year. Investment securities accounted for ¥504.8B, or 50.4%, of total assets of ¥1002.4B, which was the primary factor behind the low asset turnover ratio.【Financial Soundness】Liquidity was secured, with current assets of ¥189.8B versus current liabilities of ¥112.4B. Although the Company had long-term borrowings of ¥135.2B, Operating Income provided ample coverage relative to interest expenses of ¥0.7B.

Cash Flow Analysis

Although detailed disclosure of the cash flow statement was not available, an analysis of fund movements based on changes in the balance sheet indicates that cash and deposits decreased by ¥26.9B from ¥71.9B in the previous year to ¥45.0B, while long-term borrowings increased by ¥51.8B from ¥83.4B in the previous year to ¥135.2B, suggesting that borrowings may have been used to fund investments in fixed assets and the expansion of working capital. Accounts receivable increased to ¥72.8B from ¥55.5B in the previous year, while inventories increased to ¥22.5B from ¥19.2B, indicating that the buildup of working capital placed pressure on funds. Land increased substantially from ¥11.4B to more than ¥11.4B, and property, plant and equipment as a whole expanded to ¥283.0B from ¥202.5B in the previous year, indicating that asset acquisitions in investing activities were one factor contributing to funding demand. Overall, the expansion of working capital and increases in capital expenditures and borrowings appear to have been the main focus of cash management relative to profit generation from operating activities.

Earnings Quality

Current-period earnings comprise a mix of recurring earnings and temporary factors, requiring caution in evaluating their quality. The increase in Ordinary Income to ¥27.7B was largely attributable to ¥16.5B in non-operating income, primarily consisting of ¥13.7B in dividend income, while Operating Income from the core business remained at ¥12.7B. In addition, Profit Before Tax of ¥41.2B included ¥14.5B in extraordinary income from gains on the sale of investment securities, meaning that the profit level attributable to the core business would be lower if this were excluded. Net Income of ¥29.2B decreased 34.0% compared with the ¥33.6B in gains on the sale of investment securities recorded in the previous year, and both periods shared a profit structure dependent on extraordinary income. Comprehensive Income exceeded Net Income by ¥52.4B due to the expansion of valuation differences on held shares, indicating that the current period’s accrual-related fluctuations were strongly linked to market prices and must be evaluated separately from sustainable earnings power.

Earnings Forecast and Guidance

Progress against the full-year plan was 75.0% for Revenue (in line with the standard progress rate), 79.5% for Operating Income (4.5pt above the standard), 98.8% for Ordinary Income, and 104.4% for Net Income. The above-plan progress of Ordinary Income and Net Income was largely attributable to contributions from dividend income and gains on the sale of investment securities, which are non-operating and extraordinary items, respectively, and must be assessed separately from upside in the core business. Reverse-engineering the Company’s plan indicates that Net Income attributable to owners of the parent in Q4 would be calculated as a loss, suggesting that the full-year plan may have been set conservatively.

Shareholder Returns

The Q2 dividend was ¥20.00 per share, resulting in a Payout Ratio of 11.8% against cumulative Net Income of ¥29.22B. The Company’s full-year forecast is an annual dividend of ¥55.00 (interim ¥20.00, year-end ¥35.00), implying a forecast Payout Ratio of approximately 33.2% based on forecast full-year Net Income of ¥28.0B. Accumulated retained earnings of ¥342.4B support dividend stability, but because current-period earnings include the temporary factor of gains on the sale of investment securities, the sustainability of the dividend funding base must be evaluated based on recurring earnings levels.

Risk Factors

  1. Asset concentration risk: Investment securities of ¥504.8B account for 50.4% of total assets and 82.4% of net assets. The Company holds ¥273.9B in valuation differences on other securities, creating a structure in which fluctuations in the equity market have a significant impact on Comprehensive Income and net assets.

  2. Capital efficiency risk: ROE of 4.8% and ROIC of 1.7% are both low, with the total asset turnover ratio of 0.221x acting as a constraint. The Company’s ability to generate core-business earnings is relatively low compared with its substantial invested capital.

  3. Divergence in segment profitability: Segment income in the Chemical Products Business declined 17.2% YoY, and its margin also decreased by 444bp, while the expansion of Company-wide adjustment expenses partially offset profit growth in the Food Business. Continued deterioration in the profitability of the highly profitable business could weigh on Company-wide Operating Income.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

MetricCompanyMedian (IQR)Delta
Operating Income margin5.7%5.0% (4.5%–7.6%)+0.7pt
Net Income margin13.2%3.9% (2.8%–6.7%)+9.3pt

The Operating Income margin was slightly above the industry median, while the substantial outperformance of the Net Income margin was largely attributable to the contribution of extraordinary income.

Growth and Capital Efficiency

MetricCompanyMedian (IQR)Delta
Revenue growth rate (YoY)3.9%3.4% (-0.4%–4.7%)+0.5pt

The Revenue growth rate remained broadly in line with the industry median.

※Source: Compiled by the Company

Key Points from the Earnings Results

  1. Segment income in the Food Business improved substantially by +29.7% YoY, but part of this increase (¥0.6B) represented an accounting-related boost from the change in the depreciation method. The sustainability of recurring profitability improvements should be monitored in subsequent quarters.

  2. Growth in Ordinary Income and Net Income was supported by non-operating and extraordinary income and expenses, such as dividend income and gains on the sale of investment securities, and must be evaluated separately from the core-business earnings power reflected in the Operating Income margin of 5.7%.

  3. Against a backdrop in which investment securities account for more than half of total assets, ROE of 4.8% and ROIC of 1.7% represent a structural characteristic indicating the relationship between the asset composition and earnings-generating capacity.

Theoretical Share Price (Reference Value)

ScenarioTheoretical Share Price
bear¥3,055
base¥3,094
bull¥3,098
Calculation AssumptionValue
Book value per share (BPS)¥3,730
Adjusted forecast EPS¥129.4
Cost of equity r9.77% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 1.00%)
Residual income persistence coefficient ω / Explicit forecast0.62 / 5 years
Assumed Payout Ratio33.2%
Forecast EPS confidence adjustment×1.100 (based on progress ahead of the full-year forecast)
implied PBR / PER0.83x / 23.9x

Sensitivity: ¥3,009–¥3,183 at ±1% for the cost of equity, and ¥3,074–¥3,108 at ±0.1 for ω.

Notes:

  • Normalized EPS calculated from Ordinary Income and other figures is used to exclude the impact of temporary profit and loss factors (the Company’s forecast EPS is ¥165.4).
  • Because Net Income progress against the full-year forecast (104%) exceeds the standard level (75%), forecast EPS has been adjusted upward within a maximum of +10% (because companies with progress ahead of plan tend to outperform their forecasts; adjustments may be excessive for businesses with strong seasonality).
  • Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
  • Net assets as of the end of the quarter are used (there is a time lag relative to the full-year forecast).
  • Because net assets include non-controlling interests, the theoretical value may be calculated at a somewhat high level.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)


This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting professionals as necessary.

---End of Report---


AI Financial Analysis

Executive Summary

meito delivered a mixed FY2026 Q3 result: underlying sales growth continued and operating profit was broadly stable, while reported net income declined because prior-year extraordinary gains were substantially larger. Nine-month revenue increased 3.9% year on year to ¥22.13bn. Operating income rose 1.5% to ¥1.27bn. The gross margin expanded 96bp year on year to 30.5%, indicating improved product pricing and/or cost absorption. However, the SG&A ratio increased by 110bp to 24.7%, more than offsetting the gross-margin improvement. Consequently, the operating margin compressed by 13bp to 5.8%. Food was the principal earnings driver, with segment revenue up 4.0% and segment profit up 29.7%. Chemicals remained profitable but saw segment profit decline 17.2% despite 0.8% revenue growth. Real estate posted strong growth from a small base, with revenue up 29.8% and segment profit up 78.6%. Ordinary income increased 10.4% to ¥2.77bn, supported principally by ¥1.37bn of dividend income. Non-operating income was substantial at ¥1.65bn, equivalent to 7.5% of revenue, and therefore meaningfully influences earnings beyond the operating business. Profit before tax declined 33.7% to ¥4.12bn and net income fell 34.0% to ¥2.92bn, reflecting a much lower level of extraordinary gains than the previous year. Current-period extraordinary income included a ¥1.45bn gain on sales of investment securities, which lifted net income but is non-recurring. Total comprehensive income nevertheless rose 52.2% to ¥8.16bn, aided by ¥5.24bn of other comprehensive income, predominantly securities valuation effects. The reported and annualized ROE of 6.4% remains below the 8% benchmark, and the 1.7% ROIC alert points to weak returns on the enlarged capital base. The full-year forecast implies revenue growth of 5.1%, operating-income growth of 13.8%, and ordinary-income growth of 4.8%, but Q3 progress already exceeds the earnings targets. This creates scope for an upward revision if operating momentum persists, although the degree of outperformance in ordinary and net income is materially influenced by investment-related income and gains rather than solely by recurring operations.

Profitability Analysis

The annualized DuPont ROE is 6.4%, comprising a 13.2% net profit margin, 0.294x asset turnover and 1.64x financial leverage. The net margin is elevated relative to the 5.8% EBIT margin because earnings include ¥1.37bn of dividend income, ¥0.19bn of investment-securities gains and a ¥1.45bn extraordinary securities-sale gain. Accordingly, the accounting net margin does not fully represent recurring food and chemicals profitability. Asset turnover is the main structural constraint on returns, reflecting a ¥100.24bn asset base that includes ¥50.48bn of investment securities and ¥28.30bn of PPE. Financial leverage is moderate rather than aggressive at 1.64x, so leverage is not being used excessively to support ROE. Gross profit increased 7.3% to ¥6.74bn, outpacing revenue growth and expanding gross margin to 30.5% from 29.5%. SG&A increased 8.7% to ¥5.47bn, faster than revenue growth, producing the operating-margin compression to 5.8% from 5.9%. Promotion expense rose 32.4% to ¥0.28bn, consistent with a greater commercial-investment burden, although this alone does not explain all SG&A growth. The depreciation-method change to straight-line accounting increased segment profit by ¥0.70bn in aggregate, consisting of ¥0.59bn in food and ¥0.11bn in chemicals; this accounting effect supported reported segment profitability. Food is the core business by segment-profit contribution, generating ¥17.18bn of revenue and ¥1.72bn of segment profit, equivalent to 72.9% of aggregate segment profit before corporate-cost allocation. Its segment margin improved to 8.9% from 7.1%. Chemicals generated ¥2.50bn of revenue and ¥0.51bn of segment profit, with margin declining to 20.5% from 25.0%. Real estate generated ¥0.27bn of revenue and ¥0.13bn of segment profit, with margin rising to 46.3% from 33.7%, albeit on a small revenue base. The 1.7% ROIC warning is material: it indicates that operating returns on invested capital remain below a 5% minimum benchmark, principally because a large investment-security and PPE base earns a modest ¥1.27bn of operating income. This level of capital efficiency is not typical of a high-return branded food franchise and raises the importance of management improving asset utilization, returns from strategic holdings, or both.

Growth Assessment

Revenue growth was broad-based, led by the food business, which added ¥0.75bn of sales year on year. Food segment profit rose ¥0.39bn, substantially faster than sales, demonstrating improved gross-profit conversion before corporate expenses and the stated depreciation-method effect. Chemicals added only ¥0.02bn of revenue while segment profit declined ¥0.11bn, making restoration of chemical profitability a key requirement for consolidated operating-margin expansion. Real estate added ¥0.06bn of revenue and ¥0.06bn of segment profit, but its small scale limits its influence on group growth. The FY2026 forecast calls for ¥29.50bn of sales and ¥1.60bn of operating income. Q3 cumulative revenue represents 75.0% of the full-year forecast, in line with the standard 75% Q3 progress rate. Operating income represents 79.5% of forecast, 4.5 percentage points ahead of the standard pace. Ordinary income represents 98.8% of forecast, 23.8 percentage points ahead of the standard pace, largely reflecting dividend income. Net income has already reached 104.4% of the ¥2.80bn forecast, but this is supported by the securities-sale gain and should not be treated as a like-for-like indication of recurring earnings power. The forecasted full-year operating margin is 5.4%, below the Q3 cumulative 5.8%, which appears achievable if fourth-quarter operating profitability remains positive. Revenue sustainability depends most on the food segment's ability to preserve gross-margin gains while containing SG&A growth and maintaining consumer demand. For a food manufacturer, key operating sensitivities include commodity and packaging costs, energy and logistics costs, imported-input currency exposure, private-brand competition, and consumer preference shifts. Inventory days of 116 are above the 90-day warning threshold and are elevated for a food business, increasing obsolescence, demand-forecasting and inventory-carrying risks.

Financial Health

Liquidity is sound, with a 168.8% current ratio, a 148.7% quick ratio and ¥7.73bn of working capital. Current assets of ¥18.98bn exceed current liabilities of ¥11.24bn by ¥7.73bn. Cash and deposits of ¥4.50bn cover the ¥1.32bn current portion of long-term loans, limiting near-term maturity-mismatch risk. Solvency is also currently manageable: debt-to-equity is 0.64x, debt-to-capital is 18.1%, and interest coverage is a strong 17.42x. Long-term loans increased ¥5.18bn, or 62.1% year on year, to ¥13.52bn, while cash declined ¥2.19bn, or 37.4%, to ¥4.50bn. The increased debt burden warrants monitoring even though present coverage and liquidity ratios remain healthy. PPE rose ¥8.06bn, or 39.8%, to ¥28.30bn, with land rising to ¥11.43bn; this signals a materially larger fixed-asset commitment whose returns need to be validated through operating profit growth. Investment securities increased ¥7.18bn to ¥50.48bn and account for 50.4% of total assets. This large securities position supports dividend income and unrealized valuation gains but exposes equity and comprehensive income to market-price movements. Total equity increased ¥6.35bn to ¥61.26bn, including accumulated other comprehensive income of ¥27.44bn, while the capital adequacy ratio declined to 61.1% from 65.9%. The decline in cash, increase in receivables to ¥7.28bn, increase in inventories to ¥2.25bn and increase in payables to ¥3.65bn collectively indicate a more working-capital-intensive balance sheet. Treasury stock increased by ¥11.73bn in absolute negative balance, to negative ¥18.62bn, indicating substantial share repurchases or treasury-share acquisition; this reduces distributable equity flexibility and should be assessed alongside future cash generation. Goodwill is only ¥0.43bn, or 0.7% of equity and 0.4% of assets, so M&A-related goodwill impairment risk is low. Intangibles are also limited at 1.9% of assets, and no segment impairment was reported.

Notable B/S Changes

Long-term loans: +¥5.18bn (+62.1%) to ¥13.52bn - materially higher debt financing increases the required return on capital, although current interest coverage remains 17.42x. PPE: +¥8.06bn (+39.8%) to ¥28.30bn - a substantial fixed-asset expansion, including land of ¥11.43bn, raises the need for improved operating-asset productivity. Investment securities: +¥7.18bn (+16.8%) to ¥50.48bn, representing 50.4% of assets - supports dividend income but concentrates the balance sheet in market-sensitive financial assets. Cash and deposits: -¥2.19bn (-37.4%) to ¥4.50bn - liquidity remains adequate but the lower cash balance coincides with higher borrowings and greater working-capital needs. Accounts receivable: +¥1.74bn (+31.3%) to ¥7.28bn - consistent with the 90-day DSO alert and requires monitoring for collection efficiency. Accounts payable: +¥0.77bn (+26.6%) to ¥3.65bn - provides some supplier-financing offset to working-capital growth, but does not eliminate the long cash conversion cycle. Treasury stock: increased by ¥11.73bn in absolute negative balance to -¥18.62bn - indicates substantial treasury-share acquisition and reduces equity available to support future capital allocation flexibility.

Cash Flow Quality

Dividend Sustainability

The declared interim dividend is ¥20.0 per share. Against Q3 cumulative EPS of ¥173.15, the interim-only payout ratio is 11.8%. The full-year forecast dividend of ¥55.0 per share, implying a ¥35.0 per share year-end dividend, equates to a forecast dividend payout ratio of approximately 33.3% based on forecast EPS of ¥165.41. This is conservative relative to the 60% sustainability benchmark and is covered by forecast net income on an earnings basis. The enlarged treasury-stock balance indicates that shareholder returns may also include buybacks, but a total return ratio cannot be quantified from the disclosed figures. The low forecast payout leaves earnings retention capacity for debt service, working capital and fixed-asset commitments. Dividend income from investment securities supports ordinary income, but the sustainability of shareholder distributions should remain linked primarily to recurring operating cash generation and food-business profitability rather than realized securities gains.

Risk Assessment

Business risks include Food business exposure to raw-material, packaging, energy, logistics and foreign-exchange cost inflation could reverse the Q3 gross-margin improvement if price pass-through weakens., Food-safety incidents, recalls, labeling or additive regulation changes, and changing consumer preferences represent material sector-specific risks to brand demand and retailer relationships., Private-brand competition and a weak demand environment could limit pricing power and elevate promotional spending., Chemicals segment profit declined 17.2% year on year despite sales growth, indicating margin pressure and reducing diversification benefits., Investment securities equal 50.4% of assets; market-price volatility affects comprehensive income, equity and potentially gains available from portfolio sales..

Financial risks include Long-term loans increased 62.1% year on year to ¥13.52bn while cash declined 37.4% to ¥4.50bn, increasing sensitivity to refinancing conditions and interest rates despite currently strong interest coverage., Receivable days of 90 exceed the 60-day alert threshold. This indicates slower cash collection or a more credit-intensive sales mix, tying up capital and raising counterparty-credit exposure., Inventory days of 116 exceed the 90-day alert threshold. For food products, this raises aging, obsolescence and demand-forecast risks, particularly if consumer demand slows., The 141-day cash conversion cycle exceeds the 120-day alert threshold, combining elevated receivable and inventory holding periods and increasing funding requirements., The 1.7% ROIC is below the 5% warning threshold, indicating insufficient operating return on the expanded capital base..

Key concerns include The capital-efficiency alert is the highest strategic concern: ¥50.48bn of investment securities and ¥28.30bn of PPE require materially stronger recurring operating income to lift ROIC., Working-capital efficiency is a high-likelihood operational concern. DSO of 90 days, DIO of 116 days and a 141-day cash conversion cycle point to cash being locked in operations for an extended period., Reported Q3 net income includes ¥1.45bn of extraordinary investment-securities sale gains and is therefore less representative of recurring earnings than operating income., The accounting change to straight-line depreciation added ¥0.70bn to segment profit, so reported segment-profit improvement should be normalized when evaluating underlying momentum., The significant increase in debt and PPE heightens the execution risk that new or expanded assets do not generate returns commensurate with their capital cost..

Investment Implications

Key takeaways include Revenue and food-segment profit trends are constructive, with food segment margin rising to 8.9%., Consolidated operating-margin expansion remains constrained because SG&A grew faster than revenue and chemicals profitability weakened., Forecast progress is ahead of schedule for operating income and substantially ahead for ordinary and net income, but the latter two measures are supported by non-operating dividends and investment-related gains., Balance-sheet liquidity and interest coverage are healthy, but higher debt, lower cash and elongated working-capital metrics require attention., Low ROIC and a large investment-securities balance make capital allocation and asset utilization central analytical issues..

Metrics to watch include Food segment revenue growth and segment margin, Chemicals segment margin recovery, Consolidated SG&A ratio and promotion expense, Operating income versus the ¥1.60bn FY2026 forecast, Dividend income and realized investment-security gains versus recurring operating income, DSO, inventory days and cash conversion cycle, Long-term loans, cash balance, interest coverage and PPE productivity, ROIC and the proportion of assets represented by investment securities.

Regarding relative positioning, meito combines a healthy food-industry gross margin of 30.5% with a conservative liquidity profile, but its 5.8% operating margin is below the 8% level generally associated with strong profitability and its 1.7% ROIC is weak. The company is financially more resilient than a highly levered peer, yet its earnings profile is unusually influenced by investment income, securities gains and a large securities portfolio rather than being driven exclusively by operating returns.